iTBS+D-Cycloserine for Youth Suicide
RecruitingNCT06121284Phase: PHASE2Started 2024-03-11
Summary
Background and Rationale: Suicide is the second leading cause of death in Canadian Emerging Adults (EAs; 18-24yrs). Current treatments for suicidal thoughts and behaviors are limited and novel treatme
Eligibility
Sex
ALL
Min Age
18 Years
Max Age
24 Years
Locations
University of CalgaryCalgary, Alberta, Canada
View full study details on ClinicalTrials.gov
clinicaltrials.gov/study/NCT06121284